Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied DNA Sciences

0.1285
+0.00020.16%
Volume:673.86K
Turnover:88.00K
Market Cap:7.09M
PE:-0.07
High:0.1342
Open:0.1280
Low:0.1265
Close:0.1283
Loading ...

Applied DNA customer UHKT initiates Phase I clinical trial of UHKT-CAR123-01

TIPRANKS
·
18 Dec 2024

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

ACCESSWIRE
·
18 Dec 2024

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Benzinga
·
18 Dec 2024

General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday

Benzinga
·
18 Dec 2024

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
18 Dec 2024

Applied DNA Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
18 Dec 2024

BRIEF-Applied Dna Sciences Inc - Pursuing Divestiture Of Certaint Platform, Implements Changes To Corporate Leadership

Reuters
·
18 Dec 2024

Applied DNA Sciences Announces Leadership Changes and Restructuring

TIPRANKS
·
18 Dec 2024

Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
18 Dec 2024

Applied DNA Sciences Q4 2024 GAAP EPS $(0.32) Beats $(0.34) Estimate, Sales $813.11K Miss $899.00K Estimate

Benzinga
·
18 Dec 2024

Applied DNA Sciences Inc - Net Loss for Q4 of Fiscal 2024 Was $0.32 per Share

THOMSON REUTERS
·
18 Dec 2024

Applied DNA Sciences Inc - Pursuing Divestiture of Certaint Platform, Implements Changes to Corporate Leadership

THOMSON REUTERS
·
18 Dec 2024

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

ACCESSWIRE
·
18 Dec 2024

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

ACCESSWIRE
·
16 Dec 2024

Applied DNA Sciences Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
14 Dec 2024

Applied DNA Sciences Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
11 Dec 2024